These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents. Yarkoni A; Brodsky A; Sabapathy R; Pershad A Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306 [TBL] [Abstract][Full Text] [Related]
8. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience. Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580 [TBL] [Abstract][Full Text] [Related]
9. Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry. Abe M; Kimura T; Morimoto T; Taniguchi T; Yamanaka F; Nakao K; Yagi N; Kokubu N; Kasahara Y; Kataoka Y; Otsuka Y; Kawamura A; Miyazaki S; Nakao K; Horiuchi K; Ito A; Hoshizaki H; Kawaguchi R; Setoguchi M; Inada T; Kishi K; Sakamoto H; Morioka N; Imai M; Shiomi H; Nonogi H; Mitsudo K; Circulation; 2010 Jul; 122(1):42-51. PubMed ID: 20566954 [TBL] [Abstract][Full Text] [Related]
10. [Efficiency of medical versus endovascular treatment using drug-eluting stents in coronary heart disease patients with extensive lesion of the coronary bed]. Savost'ianov KA; Cherkavskaia OV; Savchenko AP; Rudenko BA Vestn Rentgenol Radiol; 2011; (5):11-6. PubMed ID: 22420204 [TBL] [Abstract][Full Text] [Related]
11. Revascularization of left anterior descending artery with drug-eluting stents: comparison with minimally invasive direct coronary artery bypass surgery. Ben-Gal Y; Mohr R; Braunstein R; Finkelstein A; Hansson N; Hendler A; Moshkovitz Y; Uretzky G Ann Thorac Surg; 2006 Dec; 82(6):2067-71. PubMed ID: 17126111 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A; J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982 [TBL] [Abstract][Full Text] [Related]
13. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome. Vassiliades TA; Douglas JS; Morris DC; Block PC; Ghazzal Z; Rab ST; Cates CU J Thorac Cardiovasc Surg; 2006 May; 131(5):956-62. PubMed ID: 16678575 [TBL] [Abstract][Full Text] [Related]
14. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798 [TBL] [Abstract][Full Text] [Related]
15. [Long-term results of coronary endovascular revascularisation with sirolimus-eluting stents in patients with ischemic heart disease comorbid with type-2 diabetes mellitus: data from 18-month prospective study]. Tepliakov AT; Torim IuIu; Kuznetsova AV; Rybal'chenko EV; Krylov AL; Karpov RS Ter Arkh; 2009; 81(5):54-60. PubMed ID: 19537588 [TBL] [Abstract][Full Text] [Related]
16. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results. Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585 [TBL] [Abstract][Full Text] [Related]
17. Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels. Hoffmann R; Hamm C; Nienaber CA; Levenson B; Bonzel T; Sabin G; Senges J; Zahn R; Tebbe U; Pfannebecker T; Richardt HG; Schneider S; Kelm M; Coron Artery Dis; 2007 Nov; 18(7):559-64. PubMed ID: 17925610 [TBL] [Abstract][Full Text] [Related]
18. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions. Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862 [TBL] [Abstract][Full Text] [Related]
19. Revascularization of the left anterior descending artery with drug-eluting stents: comparison with arterial off-pump surgery. Herz I; Mohr R; Moshkovitz Y; Ben-Gal Y; Adam SZ; Braunstein R; Uretzky G Heart Surg Forum; 2004; 7(5):E490-2. PubMed ID: 15799931 [TBL] [Abstract][Full Text] [Related]
20. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]